news
Blocking the IL-6 receptor to protect tissues from CRS
The new study’s findings suggest that CRS can be treated with an IL-6 receptor antibody that has a short half-life.
List view / Grid view
The new study’s findings suggest that CRS can be treated with an IL-6 receptor antibody that has a short half-life.